Journal article

Gut microbiome, prebiotics, intestinal permeability and diabetes complications

Matthew Snelson, Cassandra de Pasquale, Elif I Ekinci, Melinda T Coughlan

BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM | ELSEVIER SCI LTD | Published : 2021

Abstract

Diabetes is a metabolic condition. The composition of the gut microbiota is altered in diabetes with reduced levels of short chain fatty acids (SCFA) producers, notably butyrate. Butyrate is associated with a number of beneficial effects including promoting the integrity of the gastrointestinal barrier. Diabetes may lead to an increase in the permeability of the gut barrier, which is thought to contribute to systemic inflammation and worsen the microvascular complications of diabetes. Prebiotics, non-digestible carbohydrates, are fermented by the colonic microbiota leading to the production of a range of metabolites including SCFAs. Thus, prebiotics represent a dietary approach to increase l..

View full abstract

University of Melbourne Researchers